Page last updated: 2024-09-26

alpha-ribazole

Cross-References

ID SourceID
PubMed CID160433
CHEBI ID10329
SCHEMBL ID1332720
MeSH IDM0064790

Synonyms (22)

Synonym
(2s,3r,4s,5r)-2-(5,6-dimethylbenzimidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
(5s,2r,3r,4r)-5-(5,6-dimethylbenzimidazolyl)-2-(hydroxymethyl)oxolane-3,4-diol
CHEBI:10329
5,6-dimethyl-1-alpha-d-ribofuranosyl-1h-benzimidazole
132-13-8
ALPHA-RIBAZOLE ,
n1-(alpha-d-ribosyl)-5,6-dimethylbenzimidazole
C05775
(2s,3r,4s,5r)-2-(5,6-dimethylbenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
SCHEMBL1332720
1h-benzimidazole, 5,6-dimethyl-1-alpha-d-ribofuranosyl-
1-alpha-d-ribofuransido-5,6-dimethylbenzimidazole
ena499945f ,
unii-ena499945f
.alpha.-ribazole
.alpha.-ribazole [mi]
1h-benzimidazole, 5,6-dimethyl-1-.alpha.-d-ribofuranosyl-
5,6-dimethylbenzimidazole-.alpha.-d-ribofuranoside
5,6-dimethyl-1-(.alpha.-d-ribofuranosyl)benzimidazole
5,6-dimethyl-1-(alpha-d-ribofuranosyl)benzimidazole
Q27108618
DTXSID201030606

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
1-ribosylbenzimidazole
dimethylbenzimidazole
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

alpha-ribazole is involved in 1 pathway(s), involving a total of 2 unique proteins and 12 unique compounds

PathwayProteinsCompounds
adenosylcobalamin biosynthesis from adenosylcobinamide-GDP II212

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (18.18)18.7374
1990's1 (9.09)18.2507
2000's2 (18.18)29.6817
2010's3 (27.27)24.3611
2020's3 (27.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]